Silo Pharma, Inc. (SILO)
NASDAQ·Healthcare·Biotechnology
$0.45
+2.24%
Mkt Cap $2.76M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | — | $18.03K | — | — | -$0.07 | — | — | — |
| Q4 2025 Nov 13, 2025 | — | $18.02K | — | — | -$0.12 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | $18.02K | — | — | -$0.19 | — | — | — |
| Q2 2025 May 9, 2025 | — | $18.03K | — | — | -$0.23 | — | — | — |
| Q1 2025 Mar 28, 2025 | — | $18.03K | — | — | -$0.41 | — | — | — |
| Q4 2024 Nov 12, 2024 | — | $18.02K | — | — | -$0.22 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | $18.02K | — | — | -$0.31 | — | — | — |
| Q2 2024 May 13, 2024 | — | $18.03K | — | — | -$0.28 | — | — | — |
| Q1 2024 Mar 25, 2024 | $18.00K | $18.03K | +0.14% | -$0.20 | -$0.36 | -80.00% | — | — |
| Q4 2023 Nov 13, 2023 | $18.00K | $18.02K | +0.14% | -$0.21 | -$0.21 | +0.00% | — | — |
| Q3 2023 Aug 12, 2023 | $18.00K | $18.02K | +0.14% | -$0.32 | -$0.32 | -0.37% | — | — |
| Q2 2023 May 12, 2023 | — | $18.03K | — | — | -$0.29 | — | — | — |
| Q1 2023 Mar 24, 2023 | — | $18.03K | — | — | -$0.78 | — | — | — |
| Q4 2022 Nov 10, 2022 | — | $18.02K | — | — | -$0.51 | — | — | — |
| Q3 2022 Aug 1, 2022 | — | $18.02K | — | — | -$0.41 | — | — | — |
| Q2 2022 May 13, 2022 | — | $18.03K | — | — | -$0.31 | — | — | — |
| Q1 2022 Mar 28, 2022 | — | $18.03K | — | — | -$0.57 | — | — | — |
| Q4 2021 Nov 11, 2021 | — | $18.02K | — | — | $3.20 | — | — | — |
| Q3 2021 Aug 13, 2021 | — | $68.08K | — | — | -$0.24 | — | — | — |
| Q2 2021 May 17, 2021 | — | $47.43K | — | — | -$0.55 | — | — | — |